FR1460571A - Thienyl acetic compounds and their preparation - Google Patents

Thienyl acetic compounds and their preparation

Info

Publication number
FR1460571A
FR1460571A FR20206A FR20206A FR1460571A FR 1460571 A FR1460571 A FR 1460571A FR 20206 A FR20206 A FR 20206A FR 20206 A FR20206 A FR 20206A FR 1460571 A FR1460571 A FR 1460571A
Authority
FR
France
Prior art keywords
preparation
thienyl acetic
acetic compounds
compounds
thienyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR20206A
Other languages
French (fr)
Inventor
Andre Lucien Pons
Max Fernand Robba
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Innothera SAS
Original Assignee
Laboratoires Innothera SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Innothera SAS filed Critical Laboratoires Innothera SAS
Priority to FR20206A priority Critical patent/FR1460571A/en
Application granted granted Critical
Publication of FR1460571A publication Critical patent/FR1460571A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR20206A 1965-06-10 1965-06-10 Thienyl acetic compounds and their preparation Expired FR1460571A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR20206A FR1460571A (en) 1965-06-10 1965-06-10 Thienyl acetic compounds and their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR20206A FR1460571A (en) 1965-06-10 1965-06-10 Thienyl acetic compounds and their preparation

Publications (1)

Publication Number Publication Date
FR1460571A true FR1460571A (en) 1966-03-04

Family

ID=8581448

Family Applications (1)

Application Number Title Priority Date Filing Date
FR20206A Expired FR1460571A (en) 1965-06-10 1965-06-10 Thienyl acetic compounds and their preparation

Country Status (1)

Country Link
FR (1) FR1460571A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2511368A1 (en) * 1981-08-11 1983-02-18 Madaus Cerafarm Lab 5'-SUBSTITUTED 2- (3'-THIENYL) -PROPIONIC ACIDS, PROCESS FOR PREPARING THEM AND THEIR APPLICATION AS MEDICAMENTS
WO2004017964A1 (en) 2002-08-19 2004-03-04 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
WO2007062314A2 (en) 2005-11-23 2007-05-31 Bristol-Myers Squibb Company Heterocyclic cetp inhibitors
WO2007105050A1 (en) 2006-03-10 2007-09-20 Pfizer Products Inc. Dibenzyl amine compounds and derivatives
WO2007105049A1 (en) 2006-03-10 2007-09-20 Pfizer Products Inc. Dibenzyl amine derivatives as cetp inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
EP2392567A1 (en) 2005-10-21 2011-12-07 Bristol-Myers Squibb Company Benzothiazine derivatives and their use as lxr modulators
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2511368A1 (en) * 1981-08-11 1983-02-18 Madaus Cerafarm Lab 5'-SUBSTITUTED 2- (3'-THIENYL) -PROPIONIC ACIDS, PROCESS FOR PREPARING THEM AND THEIR APPLICATION AS MEDICAMENTS
WO2004017964A1 (en) 2002-08-19 2004-03-04 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
EP2392567A1 (en) 2005-10-21 2011-12-07 Bristol-Myers Squibb Company Benzothiazine derivatives and their use as lxr modulators
WO2007062314A2 (en) 2005-11-23 2007-05-31 Bristol-Myers Squibb Company Heterocyclic cetp inhibitors
WO2007105050A1 (en) 2006-03-10 2007-09-20 Pfizer Products Inc. Dibenzyl amine compounds and derivatives
WO2007105049A1 (en) 2006-03-10 2007-09-20 Pfizer Products Inc. Dibenzyl amine derivatives as cetp inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Similar Documents

Publication Publication Date Title
MC509A1 (en) New substituted benzylsulfonamides and their preparation
FR1460571A (en) Thienyl acetic compounds and their preparation
MC511A1 (en) New heterocyclic compounds and their preparation
FR1505966A (en) Thieno-benzo-thiazepinones and their preparation
FR1517823A (en) D-homo-steroids and their preparation
FR1505241A (en) Substituted thiocyano-pyrroles and their preparation
FR1462206A (en) Gem-bithienyl compounds and their preparation
FR1460176A (en) New aryl compounds and their preparation
FR1461994A (en) N-vinyl-n-alkyl-formamides and their preparation
FR1458540A (en) Acrylic sulfur compounds and their preparation
FR1479120A (en) Imidazole compounds and their preparation
FR1506734A (en) Dibenzoazepine compounds and their preparation
FR1490038A (en) New 5-nitro-furyl compounds and their preparation
MC633A1 (en) Benzene-sulfonyl-ureas and their preparation
FR1447532A (en) Dimercapto-triazoles and their preparation
FR87378E (en) Benzylguanidines and their preparation
FR1499847A (en) Heterocyclic compounds and their preparation
FR1434449A (en) New dibenzoazepine compounds and their preparation
FR1501498A (en) Azepin compounds and their preparation
FR1480455A (en) Methano-benzazocines and their preparation
FR1515092A (en) Tetracosapeptides and their preparation
FR1476463A (en) Dihydro-anthracenes and their preparation
FR1445497A (en) Tetravinylpolysiloxanes and their preparation
FR1535533A (en) Thieno-benzothiazepines and their preparation
FR1477463A (en) Thiepinic and oxepinnic compounds and their preparation